Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- PMID: 29562192
- DOI: 10.1016/j.immuni.2018.03.004
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Abstract
Owing to their tremendous diversity and plasticity, immune cells exert multifaceted functions in tumor-bearing hosts, ranging from anti-tumor to pro-tumor activities. Tumor immune landscapes differ greatly between and within cancer types. Emerging evidence suggests that genetic aberrations in cancer cells dictate the immune contexture of tumors. Here, we review the current understanding of the mechanisms whereby common drivers of tumorigenesis modulate the tumor immune milieu. We discuss these findings in the context of clinical observations and examine how cancer-cell-intrinsic properties can be exploited to maximize the benefit of immunomodulatory therapies. Understanding the relationship between cancer cell-intrinsic genetic events and the immune response may enable personalized immune intervention strategies for cancer patients.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.Mol Cancer. 2022 Jan 21;21(1):27. doi: 10.1186/s12943-021-01486-5. Mol Cancer. 2022. PMID: 35062950 Free PMC article. Review.
-
Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance.Front Immunol. 2021 May 17;12:657293. doi: 10.3389/fimmu.2021.657293. eCollection 2021. Front Immunol. 2021. PMID: 34079545 Free PMC article. Review.
-
Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?Cancer Immunol Res. 2016 Apr;4(4):269-78. doi: 10.1158/2326-6066.CIR-16-0011. Cancer Immunol Res. 2016. PMID: 27036971 Free PMC article. Review.
-
Editorial: Immune Cell Lineage Reprogramming in Cancer.Front Immunol. 2022 Jan 19;12:838464. doi: 10.3389/fimmu.2021.838464. eCollection 2021. Front Immunol. 2022. PMID: 35126385 Free PMC article. No abstract available.
-
Immunosuppressive cells in tumor immune escape and metastasis.J Mol Med (Berl). 2016 May;94(5):509-22. doi: 10.1007/s00109-015-1376-x. Epub 2015 Dec 22. J Mol Med (Berl). 2016. PMID: 26689709 Review.
Cited by
-
Genetic mechanisms underlying tumor microenvironment composition and function in diffuse large B-cell lymphoma.Blood. 2024 Mar 21;143(12):1101-1111. doi: 10.1182/blood.2023021002. Blood. 2024. PMID: 38211334 Review.
-
Integrating Immunotherapy and Targeted Therapy in Cancer Treatment: Mechanistic Insights and Clinical Implications.Clin Cancer Res. 2020 Nov 1;26(21):5557-5566. doi: 10.1158/1078-0432.CCR-19-2300. Epub 2020 Jun 23. Clin Cancer Res. 2020. PMID: 32576627 Free PMC article. Review.
-
Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology.Curr Pharm Biotechnol. 2024;25(15):2012-2021. doi: 10.2174/0113892010276664231228124157. Curr Pharm Biotechnol. 2024. PMID: 38284738 Review.
-
Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC.Front Cell Dev Biol. 2022 Feb 22;10:816517. doi: 10.3389/fcell.2022.816517. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35273962 Free PMC article. Review.
-
TIGIT as an emerging immune checkpoint.Clin Exp Immunol. 2020 May;200(2):108-119. doi: 10.1111/cei.13407. Epub 2019 Dec 25. Clin Exp Immunol. 2020. PMID: 31828774 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical